Private Trust Company’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.87K Hold
350
﹤0.01% 2127
2026
Q1
$7.49K Hold
350
﹤0.01% 2070
2025
Q4
$7.49K Hold
350
﹤0.01% 2040
2025
Q3
$5.86K Hold
350
﹤0.01% 2107
2025
Q2
$5.02K Hold
350
﹤0.01% 2066
2025
Q1
$5.07K Hold
350
﹤0.01% 2020
2024
Q4
$4.59K Buy
+350
New +$4.83K ﹤0.01% 2006
2023
Q1
Sell
-15
Closed 2338
2022
Q4
$0 Buy
15
+6
+67% +$98 ﹤0.01% 2235
2022
Q3
$0 Sell
9
-6
-40% -$121 ﹤0.01% 2132
2022
Q2
$0 Buy
+15
New +$306 ﹤0.01% 2125
2017
Q3
Sell
-7,016
Closed -$423K 382
2017
Q2
$423K Hold
7,016
0.09% 261
2017
Q1
$486K Buy
+7,016
New +$487K 0.11% 216
2014
Q4
Sell
-404
Closed -$22K 810
2014
Q3
$22K Sell
404
-32
-7% -$1.82K 0.01% 813
2014
Q2
$25K Buy
436
+338
+345% +$19.9K 0.01% 772
2014
Q1
$6K Sell
98
-4
-4% -$233 ﹤0.01% 1123
2013
Q4
$5K Sell
102
-52
-34% -$2.79K ﹤0.01% 1166
2013
Q3
$8K Sell
154
-4
-3% -$195 ﹤0.01% 994
2013
Q2
$7K Buy
+158
New +$7.07K ﹤0.01% 966

Other funds holding MD

Private Trust Company's MD Position: Q2 2026 in Review

Private Trust Company held its Pediatrix Medical (MD) position steady in Q2 2026 at 350 shares worth $8.87K. The position accounts for ﹤0.01% of the portfolio, ranked #2127.

Private Trust Company first reported a position in MD in Q2 2013 and has held it in 18 quarters since. The position peaked at $486K in Q1 2017. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Private Trust Company held 350 shares of Pediatrix Medical worth $8.87K as of Q2 2026.
  • Private Trust Company left its Pediatrix Medical share count unchanged in Q2 2026.
  • Pediatrix Medical made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2127 holding.
  • Private Trust Company first reported a position in Pediatrix Medical in Q2 2013 and has held it in 18 quarters since.
  • Private Trust Company's Pediatrix Medical position peaked at $486K in Q1 2017.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.